HealthTree

Brentuximab Vedotin Combo Shows Improvement in DLBCL Survival

Brentuximab Vedotin Combo Shows Improvement in DLBCL Survival image

HealthTree Cure Tour: Syracuse with Drs. Malek and Ghimire

HealthTree Cure Tour: Syracuse with Drs. Malek and Ghimire

Living Beyond DLBCL: Minimizing Cardiovascular Risks

Living Beyond DLBCL: Minimizing Cardiovascular Risks image

Expanding Treatment Horizons with Immunotherapy

Expanding Treatment Horizons with Immunotherapy image

Odronextamab for Lymphoma: FDA Delays Approval Decision, Trials Still Enrolling

Odronextamab for Lymphoma: FDA Delays Approval Decision, Trials Still Enrolling image

DLBCL and Follicular Lymphoma Clinical Trials at MD Anderson

Listen to this podcast with Dr. Strati to learn about trials happening at MD Anderson for DLBCL and follicular lymphonma.

DLBCL and Follicular Lymphoma Clinical Trials at MD Anderson image

Mindfulness for DLBCL Patients: Thought Defusion

Mindfulness for DLBCL Patients: Thought Defusion image

Advancing CNS Lymphoma Treatment and Research

Advancing CNS Lymphoma Treatment and Research image

High Copper and Low Zinc Consumption Disrupt p53 Function

High Copper and Low Zinc Consumption Disrupt p53 Function image

Mindfulness Technique for DLBCL Patients: Wise Mind

Mindfulness Technique for DLBCL Patients: Wise Mind image

Targeted Therapy Combinations: VVIP, VIPOR, and VIPOR-P Clinical Trials

Dr. Melani will discusses his research with three lymphoma trials: VVIP, VIPOR, and VIPOR-P.

Targeted Therapy Combinations: VVIP, VIPOR, and VIPOR-P Clinical Trials image

Research Advancements for HIV-associated Diffuse Large B-cell Lymphoma

Join us for an episode with Dr. Kathryn Lurain on advancements in HIV-associated DLBCL treatment, covering research, challenges, and future directions.

Research Advancements for HIV-associated Diffuse Large B-cell Lymphoma image

Latest Advancements in CAR-T Therapy with Dr. Ehsan Malek

Listen to learn from Dr. Ehsan Malek about some of the major breakthroughs in CAR T therapy in 2024 and what is on the horizon in 2025.

Latest Advancements in CAR-T Therapy with Dr. Ehsan Malek image

A Deep Dive into CAR T-Cell vs. Bispecific Antibodies for Relapsed or Refractory DLBCL

A Deep Dive into CAR T-Cell vs. Bispecific Antibodies for Relapsed or Refractory DLBCL image

The D.R.I.V.E. Initiative for Clinical Trial Excellence

Join Maya Birhiray, medical science liaison, to learn more about the D.R.I.VE initiative and its importance in clinical trials for lymphoma.

The D.R.I.V.E. Initiative for Clinical Trial Excellence image

ASH 2023: How Your Insurance Type May Affect Your Blood Cancer Outcome

ASH 2023: How Your Insurance Type May Affect Your Blood Cancer Outcome image

For DLBCL Patients Who Have Run Out of Options: Tafasitamab and Lenalidomide

For DLBCL Patients Who Have Run Out of Options: Tafasitamab and Lenalidomide image

HealthTree Foundation Announces Launch of HealthTree Research Hub in Multiple Myeloma

Treatment Options for Relapsed/Refractory DLBCL

Treatment Options for Relapsed/Refractory DLBCL image

Experiencing Cavities After Treatment?

Christopher

Diffuse Large B Cell Lymphoma Discussion • February 27, 2024

AI-generated title

Curious to know if anyone had a LOT (13!) of cavities following treatment. In my case, after 6 R-CHOP treatments that also left me with osteoporosis. (I’m a 59 year old man, if that makes any difference.)

MDS and CCUS Post CAR-T Therapy for DLBCL

MDS and CCUS Post CAR-T Therapy for DLBCL image

ASH 2023: Promising Ibrutinib Results for DLBCL with Central Nervous System Involvement

ASH 2023: Promising Ibrutinib Results for DLBCL with Central Nervous System Involvement image